The global Fanconi Anemia Drug Market is estimated to be valued at US$ 574.4 Million In 2023 and is expected to exhibit a CAGR Of 5.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Fanconi Anemia is a rare genetic disorder characterized by bone marrow failure, birth defects, and an increased risk of cancer. The disorder...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian